Bonjour ,
Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.
% complété
%
1 Ce profil est validé par 1 label.
Company
CRISPR STEM and THERAPEUTICS lTD
23
EQ SCORE L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Our company offers a novel procedure, a combination of cell therapy and CRISPR gene therapy, for treatment of acute myocardial infarction and ischemic heart diseases, dramatically improving the cardio protective effect and decreasing ischemic damage.
PETAH-TIKVA, PETAH-TIKVA, Israel
Send a message
Anglais
CRISPR STEM and THERAPEUTICS lTD
Anglais
Crispr Stem & Therapeutics (CST) Ltd is an Israel-based startup company that developing a patented Cardio-Protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure. Our vision is to offer a personalized cell therapy treatment, that will save lives and increase life expectancy following acute heart attack and chronic heart failure. Our protocol was tested in several proofs of concept experiments both in vitro and...
Crispr Stem & Therapeutics (CST) Ltd is an Israel-based startup company that developing a patented Cardio-Protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure. Our vision is to offer a personalized cell therapy treatment, that will save lives and increase life expectancy following acute heart attack and chronic heart failure. Our protocol was tested in several proofs of concept experiments both in vitro and in vivo in animal models and had shown dramatically decreased damage to the heart. We are proud to say that CST Ltd received the recognition from the Israeli Authorities (Tnuffa) and from the European Commission with two Seals of Excellence. Our vision that our product will be used frequently so as stents in the emergency at hospitals. CST Ltd. is looking for investors to complete the pre-clinical phase and GMP protocol (kit). For further talk and information please contact Dalia El-Ani (Ph.D) Founder & CEO
Watch Dalia El-Ani lecturer about CRISPR STEM and THERAPEUTICS LTD:
https://www.youtube.com/watch?v=SJf-HfFirk4&t=1s
Contact us:
E-mail: DaliaE@CrisprStemTherapeutics.com
Our website
http://www.CrisprStemTherapeutics.com/
Our LinkedIn:
https://www.linkedin.com/company/crispr-stem-therapeutics-ltd/posts/?feedView=all&viewAsMember=true
Dalia El-Ani LinkedIN:
https://www.linkedin.com/in/Dalia-El-Ani/
Team member(s)
Your request has been sent
Join this organization
Your request has been sent
Our network
Your request has been sent
Join this network
Your message has been sent
Certifications
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1478 Entities
Communities
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding
for selected DEEP TECH companies.
2667 Members
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.
https://access2eic.eu/
2140 Members
1604 Members
Our history
Start in 2018-company established
-
2018-company established
Company founded based on research performed under Tnufa award from the Israel Innovation Authority.
-
2019-Bootcamp
Raanana MedTech Innovation Center (Bootcamp #10)
-
2019-Seal of Excellence winner
Won two Seals of Excellence for SME phase one applications
-
2020-Merage Institute
Merage 45+ & Women Entrepreneur's Competition
to be continued ...